A UCLA Health surgical team has performed the first-in-human bladder transplant. 

Dr. Mark Litwin, UCLA Fielding School professor in the Department of Health Policy and Management and professor and chair of the Department of Urology at the David Geffen School of Medicine at UCLA, was interviewed by the Los Angeles Times about prostate cancer.

Dr. Mark Litwin, professor in the UCLA Fielding School's Department of Health Policy and Management, is a co-author of new research that found stereotactic body radiotherapy (SBRT), a form of high-dose radiation delivered in just five sessions, is as safe as conventional treatment of prostate cancer, with similar side effects and a similar impact on quality of life.

UCLA Fielding School of Public Health's Dr. Joann Elmore, professor in the Department of Health Policy and Management, co-authored an article in the Journal of the National Cancer Institute that suggests that artificial intelligence (AI) could help detect breast cancers that develop between routine screenings before they become more advanced and harder to treat.

UCLA Fielding School of Public Health alum Dr. Fola May has been elected to the American Society for Clinical Investigation, one of the oldest and most recognized medical honors societies and among the few focused on honoring the accomplishments of physician-scientists.

UCLA Fielding School of Public Health's Dr. Donatello Telesca, professor in the Department of Biostatistics, co-authored research that predicts which patients with prostate cancer are most likely to develop long-term side effects from radiation therapy.

UCLA Fielding School of Public Health's Dr. Joann Elmore, professor of Health Policy and Management, co-authored an article in the journal JAMA Insights on new requirements that all women undergoing mammography in the U.S. be informed about their breast density—a factor that affects both cancer detection and risk.

UCLA Fielding School of Public Health's Dr. Andre Nel, professor of Environmental Health Sciences, co-authored research that finds a nanoparticle both inhibited and prevented the growth of pancreatic cancer in the liver.

NBC News interviewed the UCLA Fielding School of Public Health's Dr. Jonathan Jacobs, assistant professor-in-residence of epidemiology at FSPH and a gastroenterologist and microbiome researcher, about the results of fecal transplants in cancer treatment trials. 

UCLA Fielding School of Public Health alum Dr. Fola May was interviewed on NPR's "All Things Considered"  about health disparity research.